HTG Molecular Diagnostics, Inc. Proceeds from Convertible Debt
HTG Molecular Diagnostics, Inc. reported Proceeds from Convertible Debt of $4.50 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2017-03-23
- HTG Molecular Diagnostics, Inc. proceeds from convertible debt for the quarter ending 2015-12-31 was $0.00.
- HTG Molecular Diagnostics, Inc. proceeds from convertible debt for the quarter ending 2015-09-30 was $0.00.
- HTG Molecular Diagnostics, Inc. proceeds from convertible debt for the quarter ending 2015-06-30 was $1.50M.
- HTG Molecular Diagnostics, Inc. proceeds from convertible debt for the quarter ending 2015-03-31 was $3.00M.
- HTG Molecular Diagnostics, Inc. proceeds from convertible debt for fiscal 2015 was $4.50M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $0.00 derived: sum of 2 quarters · filed 2017-03-23 | $1.50M derived: sum of 3 quarters · filed 2017-03-23 | $4.50M 10-K · filed 2017-03-23 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.50M derived: sum of 2 quarters · filed 2016-11-14 | $4.50M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.50M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $3.00M 10-Q · filed 2015-06-08 |